Table 2.
Men
|
Women
|
|||||||
---|---|---|---|---|---|---|---|---|
Yucheng | Reference group | OR* (95% CI) | AOR | Yucheng | Reference group | OR* (95% CI) | AOR | |
n | 155 | 152 | — | — | 223 | 218 | — | |
Chloracne | 66 (42.9) | 1 (0.7) | 117.0 (25.1–2,087)‡ | 111.5 (23.9–1,985)‡ | 51 (23.0) | 0 (0.0) | — | — |
Type 2 diabetes without therapy | 22 (14.4) | 22 (14.7) | 1.0 (0.5–1.8) | 1.0 (0.5–1.9) | 25 (11.3) | 12 (5.6) | 2.2 (1.1–4.7)† | 2.1 (1.1–4.5)† |
Aged <55 | 3 (4.8) | 7 (11.3) | 0.4 (0.1–1.5) | 0.5 (0.1–1.9) | 7 (4.6) | 7 (4.5) | 1.0 (0.3–3.1) | 1.0 (0.3–3.1) |
Aged 55–64 | 9 (25.0) | 5 (12.5) | 2.3 (0.7–8.3) | 3.7 (0.9–17.6) | 6 (20.7) | 0 (0.0) | — | — |
Aged ≥65 | 10 (18.2) | 10 (20.8) | 0.8 (0.3–2.2) | 0.8 (0.3–2.3) | 12 (30.8) | 5 (14.7) | 2.6 (0.8–9.1) | 2.6 (0.9–9.3) |
Type 2 diabetes with therapy | 22 (14.3) | 17 (11.3) | 1.3 (0.6–2.6) | 1.3 (0.7–2.7) | 17 (7.7) | 7 (3.2) | 2.5 (1.0–6.7) | 2.5 (1.0–6.5)† |
Aged <55 | 3 (4.8) | 3 (4.8) | 1.0 (0.2–5.7) | 1.3 (0.2–7.5) | 3 (2.0) | 5 (3.2) | 0.6 (0.1–2.5) | 0.6 (0.1–2.5) |
Aged 55–64 | 9 (25.0) | 5 (12.5) | 2.3 (0.7–8.3) | 3.7 (0.9–17.7) | 3 (10.3) | 0 (0.0) | — | — |
Aged ≥65 | 10 (17.9) | 9 (18.8) | 0.9 (0.3–2.5) | 0.9 (0.3–2.6) | 11 (28.2) | 2 (5.9) | 6.4 (1.5–43.9)† | 6.6 (1.6–45.4)† |
Hypertension with therapy | 46 (30.0) | 39 (26.0) | 1.2 (0.7–2.0) | 1.2 (0.7–2.0) | 41 (18.5) | 31 (14.4) | 1.3 (0.8–2.3) | 1.3 (0.8–2.2) |
Hypertension without therapy | 40 (26.0) | 31 (20.7) | 1.3 (0.7–2.4) | 1.3 (0.8–2.4) | 29 (13.1) | 21 (9.7) | 1.4 (0.7–2.7) | 1.4 (0.8–2.5) |
Cardiovascular disease | 22 (14.2) | 17 (11.2) | 1.3 (0.6–2.6) | 1.3 (0.7–2.6) | 30 (11.6) | 21 (9.6) | 1.4 (0.8–2.6) | 1.5 (0.8–2.7) |
Data are n (%) unless otherwise indicated.
Age adjusted.
P <0.05;
P < 0.001.